We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+9.96%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+632.23%
AUM
$51.2B
AUM Growth
+$4.14B
Cap. Flow
+$445M
Cap. Flow %
0.87%
Top 10 Hldgs %
19.89%
Holding
3,234
New
648
Increased
710
Reduced
838
Closed
835

Top Buys

Rank Stock Value
1
IVV icon
iShares Core S&P 500 ETF
IVV
+$1.99B
2
MSFT icon
Microsoft
MSFT
+$522M
3
AMD icon
Advanced Micro Devices
AMD
+$511M
4
AMZN icon
Amazon
AMZN
+$318M
5
AAPL icon
Apple
AAPL
+$317M

Top Sells

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$402M
2
MCD icon
McDonald's
MCD
+$375M
3
V icon
Visa
V
+$366M
4
META icon
Meta Platforms (Facebook)
META
+$319M
5
ADBE icon
Adobe
ADBE
+$272M

Sector Composition

Rank Sector Weight
1 Technology 19.58%
2 Healthcare 17.11%
3 Consumer Discretionary 13.31%
4 Financials 8%
5 Industrials 6.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HBM icon
2326
Hudbay
HBM
$12.4B
$68.3K ﹤0.01%
+14,219
New +$69.5K
BKCC
2327
DELISTED
BlackRock Capital Investment Corporation
BKCC
$66.2K ﹤0.01%
+20,186
New +$66K
RBOT
2328
DELISTED
Vicarious Surgical
RBOT
$66K ﹤0.01%
1,202
-4,777
-80% -$304K
BLUE
2329
DELISTED
bluebird bio
BLUE
$64.8K ﹤0.01%
+985
New +$72.1K
HBI
2330
DELISTED
Hanesbrands
HBI
$63.6K ﹤0.01%
14,000
-4,774,316
-100% -$21.8M
AXTI icon
2331
AXT Inc
AXTI
$4.83B
$62.7K ﹤0.01%
+18,219
New +$61.4K
AUTL
2332
Autolus Therapeutics
AUTL
$551M
$60.7K ﹤0.01%
+25,496
New +$60.5K
FULC icon
2333
Fulcrum Therapeutics
FULC
$286M
$57.4K ﹤0.01%
17,400
-103,600
-86% -$304K
ERX icon
2334
Direxion Daily Energy Bull 2X ETF
ERX
$238M
$57.1K ﹤0.01%
1,043
-2,057
-66% -$114K
VNET
2335
VNET Group
VNET
$2.13B
$56.8K ﹤0.01%
19,600
-1,031,610
-98% -$3.14M
MKFG
2336
DELISTED
Markforged Holding Corporation
MKFG
$54.1K ﹤0.01%
+4,470
New +$42.1K
CLRO icon
2337
ClearOne Inc
CLRO
$24M
$53.8K ﹤0.01%
+4,321
New +$90.9K
NUVB icon
2338
Nuvation Bio
NUVB
$2.32B
$52.4K ﹤0.01%
29,111
LEV
2339
DELISTED
The Lion Electric Company
LEV
$51.4K ﹤0.01%
27,782
BLND icon
2340
Blend Labs
BLND
$357M
$48.6K ﹤0.01%
+51,193
New +$45.4K
FXLV
2341
DELISTED
F45 Training Holdings Inc.
FXLV
$44K ﹤0.01%
88,004
-20,115
-19% -$17.1K
DXJ icon
2342
WisdomTree Japan Hedged Equity Fund
DXJ
$7.43B
$41.6K ﹤0.01%
+500
New +$38K
CANO
2343
DELISTED
Cano Health, Inc.
CANO
$40.2K ﹤0.01%
+289
New +$37.1K
SONDW
2344
CALL
DELISTED
Sonder Holdings Inc Warrants
SONDW
$39.8K ﹤0.01%
75,000
FXY icon
2345
PUT
Invesco CurrencyShares Japanese Yen Trust
FXY
$426M
$38.7K ﹤0.01%
600
-16,500
-96% -$1.12M
AREC icon
2346
American Resources Corp
AREC
$305M
$37.5K ﹤0.01%
19,131
-344,099
-95% -$525K
TUR icon
2347
PUT
iShares MSCI Turkey ETF
TUR
$217M
$33.9K ﹤0.01%
1,200
+600
+100% +$18.6K
XLI icon
2348
State Street Industrial Select Sector SPDR ETF
XLI
$34.5B
$32.2K ﹤0.01%
+300
New +$30.2K
CIIGW
2349
CALL
DELISTED
CIIG Capital Partners II, Inc. Warrant
CIIGW
$32.1K ﹤0.01%
13,773
-55,183
-80% -$6.14K
WFC icon
2350
Wells Fargo
WFC
$265B
$31.6K ﹤0.01%
+740
New +$29.8K

Similar funds

Marshall Wace's Q2 2023 Portfolio in Review

As of Q2 2023, Marshall Wace held 3,234 positions worth $51.2B, up 8.8% from $47.1B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Marshall Wace's Q2 2023 filing shows 648 new, 710 increased, 838 reduced and 835 closed positions. Its largest new stake was iShares Core S&P 500 ETF: 4,713,944 shares worth $2.1B. The largest sale was Gilead Sciences, an estimated $402M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Marshall Wace's largest Q2 2023 buy was iShares Core S&P 500 ETF: 4,713,944 shares worth $2.1B.
  • Marshall Wace added most to Microsoft in Q2 2023, an estimated $522M increase.
  • Marshall Wace's biggest Q2 2023 reduction was Gilead Sciences, cutting an estimated $402M.
  • Marshall Wace fully exited Cloudflare in Q2 2023, selling an estimated $136M.
  • Marshall Wace's ten largest holdings make up 20% of its $51.2B portfolio in Q2 2023.
  • Marshall Wace opened 648 new positions and closed 835 in Q2 2023.
  • Marshall Wace's portfolio value rose 8.8% quarter-over-quarter to $51.2B.

Based on Marshall Wace's 13F filing for Q2 2023, filed 14 Aug 2023.